Olema Pharmaceuticals announced that Shane Kovacs, Chief Operating and Financial Officer, is departing the company effective January 30, to pursue new opportunities. Kovacs will continue in a consulting capacity with Olema through August 1. The company will begin its search for a new CFO immediately. Dr. Bohen has assumed the role of interim Principal Financial Officer until a successor is appointed.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLMA:
- Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
- Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
- Olema Highlights Palazestrant Strategy in New Investor Presentation
- 3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
- Olema Oncology initiated with a Buy at UBS